Sibutramine maleate

马来酸西布曲明

Report date: 2022/03/09 15:08:55

Base Information

Drug NameSibutramine maleate
Drug Alias NameGL-2504
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin transporter inhibitorsDopamine transporter antagonistsNorepinephrine transporter inhibitors
TargetsNorepinephrine transporterSerotonin transporterDopamine transporter
Therapy Area/IndicationsAnorexia Nervosa
Global Approved IndicationsAnorexia Nervosa
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2011/12/01
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesAbbott Laboratories
Inactive CompaniesN/A
Active IndicationsAnorexia Nervosa
Inactive IndicationsN/A

Other Information

ATC CodeA08AA10
Related LinksN/A